The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

The US Food and Drug Administration (FDA) has approved Abbott's TriClip Transcatheter Edge-to-Edge Repair (TEER) system to repair severe tricuspid regurgitation (TR), the company has announced. The ...

Recently, catheter-based procedures have been developed to repair the tricuspid valve or reduce the leak without open surgery ...

FDA staff questioned the evidence for clinical benefit with the TriClip G4 transcatheter edge-to-edge repair (TEER) system for severe tricuspid regurgitation (TR) in documents released ahead of the ...

PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported ...

The right coronary artery and the atrioventricular node are adjacent to the annulus and are important anatomical considerations for surgical or transcatheter interventions. The right coronary artery ...

Edwards Lifesciences today shared new data demonstrating successful outcomes with its mitral and tricuspid therapies.

Please provide your email address to receive an email when new articles are posted on . In patients who had mitral valve surgery but also tricuspid regurgitation or tricuspid annular dilation, ...

Patrick O’Gara speaks with Sean Pinney about the evaluation and treatment of patients with severe tricuspid regurgitation.

Tricuspid regurgitation — a leak in the heart’s tricuspid valve that allows blood to flow back from the right ventricle to the right atrium — is relatively rare after a mitral valve repair procedure, ...

If you have severe tricuspid valve regurgitation, doctors may recommend repair or replacement surgery. The tricuspid valve is one of four valves in your heart’s four chambers. It’s on the right side ...